The largest database of trusted experimental protocols

5 protocols using cycloheximide c1988

1

Analysis of Cisplatin-Induced Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cisplatin (479306) was from Sigma (St. Louis, MO). RIP1 (610458) and JNK1 (544286) antibodies were from BD Biosciences (San Jose, CA). MKP1 (sc-370), HA (sc-805), -Xpress (sc-499) and GAPDH (sc-32233) antibodies were from Santa Cruz Biotechnology (Dallas, TX), and β-actin (A1978) was from Sigma (St. Louis, MO). Phospho-JNK (44-682G) antibody was from Invitrogen (Camarillo, CA). Anti-phospho-MKK4 (cs-9156s) and total MKK4 (CS-9152) were from Cell Signaling Technology (Danvers, MA). MG-132 (474790) was from Calbiochem. Chloroquine (C6628) and Cycloheximide (C1988) were from Sigma. Anti-hsa-miRNA-940 (MIN0004983) miScript miRNA inhibitor targeting miR-940 was from QIAGEN (Germantown, MD).
+ Open protocol
+ Expand
2

Ubiquitin-Proteasome Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cycloheximide (C1988), protease inhibitor cocktail SIGMAFAST™ (S8820), agarose- anti-FLAG® M2 (A2220), agarose-anti-HA (E6779) beads, FLAG® peptide (F3290), HA peptide (I2149), primers were all purchased from Sigma-Aldrich. Antibodies to HA (H3663) (1:1000), FLAG® M2 (F1804) (1:500), Fbxo7 (SAB1407251) (1:1000), GAPDH (G8795) (1:10000) and actin (A3853) (1:2000) were purchased from Sigma-Aldrich. Rabbit antibodies to Fbxo7 (ARP43128) (1:1000) were purchased from Aviva Systems Biology; antibodies against β-actin were purchased from Merck Millipore (MAB1501) (1:10000); and against the myc epitope (#2272) (1:1000), anti-K63 polyubiquitin (#5621) (1:500), anti-K48 polyubiquitin (#8081) (1:1000), anti-AKT (#4691) (1:1000) anti- Histone H3 (1B1B2) (1:1000) were purchased from Cell Signaling Technologies. Human ubiquitin (U—100H), ubiquitin N-terminal biotin (UB-560), His-ubiquitin E1 enzyme (UBE1) (E-304), UbcH5a/UBE2D1 (E2-616), 10× ubiquitin conjugation reaction buffer (B-70), Mg-ATP Solution (B-20) and the proteasome inhibitor MG132 (I-130) were purchased from Boston Biochem.
+ Open protocol
+ Expand
3

Antibody Characterization and Reagent Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-HDAC1 antibody was previously generated in our laboratory69 (link). Anti-FLAG M2 (F1804) and anti-β-actin (A1978) antibodies were purchased from Sigma-Aldrich (St. Louis, MO). Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH, HRP-60004) antibody was from Proteintech (Rosemont, IL). Anti-Lamin A (sc-20680) and anti-HA tag (sc-805) antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX). Anti-EGFR (A300-388A) antibody was from Bethyl Laboratories (Montgomery, TX). Anti-phospho-EGFR (Y1173) (AF1095) antibody was from R&D Systems (Minneapolis, MN). Anti-Bim (2876) and anti-Myc tag (9B11, 2276) antibodies were from Cell Signaling Technology (Danvers, MA). Phosphotyrosine antibody cocktail (13-6620) was from Invitrogen (Thermo Fisher Scientific, Waltham, MA). Mouse (NA931) and Rabbit (NA934) IgG HRP-linked antibodies were purchased from GE Healthcare (Chicago, IL).
Rhodamine Phalloidin (PHDR1) was from Cytoskeleton (Denver, CO). Epidermal Growth Factor (EGF; cat. 236-EG) was purchased from R&D Systems. Gefitinib (ZD1839) was from Cayman Chemical Company (Ann Arbor, MI). AG-1478 (A8357) and MG-132 (A2585) were from ApexBio (Houston, TX). Cycloheximide (C1988) and leptomycin B (L2913) were purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
4

Monitoring Protein Degradation Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type and mutant seedlings were germinated on 0.5X MS media (Murashige and Skoog, 1962) for 4 days. On day 5, 30 seedlings of each genotype were transferred to 24 well-plates containing 1 ml 0.5X MS supplemented with 50 M MG132 (474787, Sigma-Aldrich). Plates were sealed with surgical tape and placed on a shaker at 55 rpm for 16 h at 23 o C under continuous light. After 16 h, the seedlings were washed 3X with 1 ml fresh media. Cycloheximide (C1988, Sigma-Aldrich) (400 M in DMSO) or DMSO control was added at 0 h, and harvesting occurred at 0, 2, 4, 5, 8, 10 or 24 h, respectively. Samples of 30 seedlings were flash frozen in liquid nitrogen and stored at -80°C prior to protein extraction. Tissue was homogenized in liquid nitrogen, and hot SDS buffer (8 M urea, 2% SDS, 0.1 M DTT, 20% glycerol, 0.1 M Tris-Cl pH 6.8, 0.004% bromophenol blue) was added prior to SDS-PAGE and Western blotting. Anti-GFP (1:2000; 11814460001, Roche) served as the primary Ab, followed by secondary Goat Anti-Mouse IgG [HRP] (1:3000; A00160, Genscript). Proteins were detected with SuperSignal West Femto Maximum Sensitivity Substrate (ThermoFisher Scientific) using an Azure 300 chemiluminescence imager (Azure Biosystems), and blots were stained with Bio-Safe Coomassie Blue G-250 (Bio-Rad) for loading controls. Band intensities were quantified ImageJ software.
+ Open protocol
+ Expand
5

Cell Culture and Genetic Manipulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture and treatments 293T and A549 cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). All cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum in a 5% CO2/95% air at 37°C under saturated humidity. Dulbecco's modified Eagle's medium, fetal bovine serum, trypsin, were obtained from Invitrogen (Carlsbad, CA, USA). MLN4924 (HY-10484) was purchased from Medkoo (North Carolina, USA). Puromycin (P9620), MG132 (M8699) and cycloheximide (C1988) were obtained from Sigma (St. Louis, MO, U.S.A). shRNAs shRNAs against FBXO6 (TRCN0000424635, TRCN0000007733), Ero1L (TRCN0000300619, TRCN0000300621) and pLKO.1 vector were purchased from Sigma (St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!